What is Prevenna?
Prevenna operates at the intersection of advanced diagnostics and personalized medicine, offering a comprehensive suite of preventative screenings and tailored wellness plans. The company distinguishes itself by providing an end-to-end healthcare experience, where early risk identification for conditions such as heart disease is seamlessly integrated with actionable treatment pathways. By operating physical locations in Dallas and Forney and maintaining partnerships with major insurance providers, Prevenna effectively bridges the gap between clinical diagnostics and long-term patient health optimization. Their model is designed to shift the healthcare paradigm from reactive treatment to proactive risk mitigation, thereby improving patient outcomes and reducing long-term systemic costs.
How much funding has Prevenna raised?
Prevenna has raised a total of $38K across 1 funding round:
Debt
$38K
Debt (2021): $38K with participation from PPP
Key Investors in Prevenna
PPP
Public-Private Partnership
What's next for Prevenna?
With the recent infusion of capital, Prevenna is poised to accelerate its operational footprint and refine its diagnostic technology stack. The strategic focus will likely center on expanding its service delivery model to additional markets, thereby increasing accessibility for patients seeking high-touch, preventative care. As the company matures through its current growth stage, management will likely prioritize the integration of data-driven health insights to further personalize patient treatment plans. This expansion phase is critical for establishing Prevenna as a leader in the preventative health space, as the firm continues to demonstrate the efficacy of its integrated care model in reducing the incidence of chronic health conditions.
See full Prevenna company page
